Division of Immunology, University Children's Hospital Zurich, Zurich, Switzerland.
Children's Research Center, University Children's Hospital, University of Zurich, Zurich, Switzerland.
Immunology. 2018 Feb;153(2):145-160. doi: 10.1111/imm.12865. Epub 2017 Dec 18.
The advent of next-generation sequencing (NGS) now allows a detailed assessment of the adaptive immune system in health and disease. In particular, high-throughput B-cell receptor (BCR) repertoire sequencing provides detailed information about the functionality and abnormalities of the B-cell system. However, it is mostly unknown how the BCR repertoire is altered in the context of primary immunodeficiencies (PID) and whether findings are consistent throughout phenotypes and genotypes. We have performed an extensive literature search of the published work on BCR repertoire sequencing in PID patients, including several forms of predominantly antibody disorders and combined immunodeficiencies. It is somewhat surprising that BCR repertoires, even from severe clinical phenotypes, often show only mild abnormalities and that diversity or immunoglobulin gene segment usage is generally preserved to some extent. Despite the great variety of wet laboratory and analytical methods that were used in the different studies, several findings are common to most investigated PIDs, such as the increased usage of gene segments that are associated with self-reactivity. These findings suggest that BCR repertoire characteristics may be used to assess the functionality of the B-cell compartment irrespective of the underlying defect. With the use of NGS approaches, there is now the opportunity to apply BCR repertoire sequencing to multiple patients and explore the PID BCR repertoire in more detail. Ultimately, using BCR repertoire sequencing in translational research could aid the management of PID patients by improving diagnosis, estimating functionality of the immune system and improving assessment of prognosis.
下一代测序(NGS)的出现现在允许在健康和疾病中对适应性免疫系统进行详细评估。特别是,高通量 B 细胞受体(BCR)库测序提供了有关 B 细胞系统功能和异常的详细信息。然而,在原发性免疫缺陷(PID)的背景下,BCR 库如何改变以及这些发现是否在表型和基因型上一致,这在很大程度上是未知的。我们对 PID 患者的 BCR 库测序的已发表工作进行了广泛的文献检索,包括几种主要的抗体疾病和联合免疫缺陷。令人有些惊讶的是,BCR 库,即使来自严重的临床表型,通常也仅显示轻度异常,并且多样性或免疫球蛋白基因片段的使用通常在某种程度上得到保留。尽管在不同的研究中使用了各种湿实验室和分析方法,但大多数研究的 PID 有几个共同的发现,例如与自身反应相关的基因片段的使用增加。这些发现表明,BCR 库特征可用于评估 B 细胞区室的功能,而与潜在缺陷无关。随着 NGS 方法的应用,现在有机会对多个患者进行 BCR 库测序,并更详细地研究 PID 的 BCR 库。最终,在转化研究中使用 BCR 库测序可以通过改善诊断、评估免疫系统的功能和改善预后评估来帮助 PID 患者的管理。